Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Here's What to Expect From CME Group's Next Earnings Report

January 14, 2026 at 07:20 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CME Group Inc. (CME), headquartered in Chicago, Illinois, operates contract markets for the trading of futures and options on futures contracts. Valued at $95.6 billion by market cap, the company offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, and more. It facilitates trading on its trading floors, electronic platform, and through privately negotiated transactions that it clears. The leading derivatives marketplace is expected to announce its fiscal fourth-quarter earnings for 2025 before the market opens on Wednesday, Feb. 4.

Ahead of the event, analysts expect CME to report a profit of $2.72 per share on a diluted basis, up 7.9% from $2.52 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

For the full year, analysts expect CME to report EPS of $11.17, up 8.9% from $10.26 in fiscal 2024. Its EPS is expected to rise 4% year over year to $11.62 in fiscal 2026.

CME stock has underperformed the S&P 500 Index’s ($SPX) 19.3% gains over the past 52 weeks, with shares up 17% during this period. However, it outperformed the Financial Select Sector SPDR Fund’s (XLF) 13.8% gains over the same time frame.

On Oct. 22, 2025, CME shares closed down marginally after reporting its Q3 results. Its adjusted EPS of $2.68 topped Wall Street expectations of $2.63. The company’s revenue was $1.54 billion, topping Wall Street forecasts of $1.53 billion.

Analysts’ consensus opinion on CME stock is moderately bullish, with a “Moderate Buy” rating overall. Out of 17 analysts covering the stock, five advise a “Strong Buy” rating, two suggest a “Moderate Buy,” seven give a “Hold,” one recommends a “Moderate Sell,” and two advocate a “Strong Sell.” CME’s average analyst price target is $292.33, indicating a potential upside of 8.9% from the current levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article